Research Papers:

Circular RNA hsa_circ_0021001 in peripheral blood: a potential novel biomarker in the screening of intracranial aneurysm

Lingfang Teng, Yu Chen, Huihui Chen, Xijun He, Junyou Wang, Yujiang Peng, Hongyu Duan, Huiyong Li, Da Lin and Bo Shao _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:107125-107133. https://doi.org/10.18632/oncotarget.22349

Metrics: PDF 1128 views  |   HTML 2140 views  |   ?  


Lingfang Teng1, Yu Chen1, Huihui Chen1, Xijun He1, Junyou Wang1, Yujiang Peng1, Hongyu Duan1, Huiyong Li1, Da Lin1 and Bo Shao1

1Department of Neurosurgery, The First People’s Hospital of Wenling, Wenling 317500, Zhejiang Province, China

Correspondence to:

Bo Shao, email: [email protected]

Keywords: circular RNAs (circRNAs); intracranial aneurysms (IA); disease-free survival (DFS); overall survival (OS); diagnosis

Received: July 25, 2017    Accepted: August 28, 2017    Published: November 10, 2017


Circular RNAs (circRNAs) in the peripheral blood have been reported to be associated with cancer. However, there are few studies about circRNAs in intracranial aneurysms (IA). The purpose of the current study was to investigate the characteristic expression of circular RNA hsa_circ_0021001 in the peripheral blood of patients with intracranial aneurysms and its potential as a diagnostic biomarker for IA. In this study, a cohort of 223 cases of IA patients who were admitted in the department of neurosurgery in the First People’s Hospital of Wenling from January 2009 to July 2012 were collected as the experimental group, and 131 healthy volunteers over the same period served as the control group. Peripheral blood of each subject in both groups was collected on an empty stomach. The expression of hsa_circ_0021001 in peripheral blood was detected by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and the difference was analyzed by paired t-test. The effectiveness of hsa_circ_0021001 in the diagnosis of IA was assessed by ROC curve. Multivariate Cox proportional hazards regression analysis was used to analyze the prognosis. Hsa_circ_0021001 level in the peripheral blood of IA patients was relatively lower than that in the control group (P=0.002). The area under ROC (AUC) was 0.87, indicating that hsa_circ_0021001 was highly effective in the diagnosis of IA. In addition, hsa_circ_0021001 expression was correlated with aneurysm rupture, Hunt, Hess level, and timing of surgery (P= 0.041, 0.013, and 0.001, respectively). Patients with high expression of hsa_circ_0021001 had longer disease-free survival (DFS) and overall survival (OS) (P < 0.05). We found for the first time that hsa_circ_0021001 decreased significantly in the peripheral blood of IA patients, which suggested that hsa_circ_0021001 might be used as a potential novel marker for the diagnosis of IA.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22349